Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2004

Feb 17, 2004

34519_dirs_2004-02-17_61a5bffc-6728-43f8-90fc-20027d44931a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-02-12

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-02-12 Common Stock, par value $0.10 per share P 400 $4.22 Acquired 361060 Direct
2004-02-12 Common Stock, par value $0.10 per share P 300 $4.23 Acquired 361360 Direct
2004-02-12 Common Stock, par value $0.10 per share P 800 $4.21 Acquired 362160 Direct
2004-02-12 Common Stock, par value $0.10 per share P 400 $4.22 Acquired 362560 Direct
2004-02-12 Common Stock, par value $0.10 per share P 400 $4.23 Acquired 362960 Direct
2004-02-13 Common Stock, par value $0.10 per share P 300 $4.19 Acquired 363260 Direct
2004-02-13 Common Stock, par value $0.10 per share P 200 $4.19 Acquired 363460 Direct
2004-02-13 Common Stock, par value $0.10 per share P 600 $4.22 Acquired 364060 Direct
2004-02-13 Common Stock, par value $0.10 per share P 800 $4.20 Acquired 364860 Direct
2004-02-13 Common Stock, par value $0.10 per share P 400 $4.16 Acquired 365260 Direct
2004-02-17 Common Stock, par value $0.10 per share P 600 $4.25 Acquired 365860 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.